Introduction
With a prevalence of 13.1% chronic kidney disease (CKD) is one of the most common diseases in the United States [1] . Due to a failure of the kidneys, CKD patients suffer from an alteration of the blood serum electrolyte concentrations. Sodium, potassium and calcium influence the electrophysiology of the heart. Therefore, patients suffering from CKD are at a higher risk to experience cardiovascular diseases (CVD). The death rate due to CVD is 10 to 30x higher in dialysis patients than in patients without CKD [2] . In order to study the relation between both diseases, the influence of a variation of the electrolyte concentrations on the cardiac signals needs to be investigated. Moreover, recent studies suggest a crucial role of hypocalcemia in the pathophysiology of bradycardic sudden cardiac death in CKD patients [3] . El Sherif and Turito [4] report an action potential duration (APD) prolongation and a QT prolongation during hypocalcemia. However, in vivo studies are generally very limited, expensive and associated with ethical issues, especially when performed in humans. Therefore, computational cardiac modelling is a valuable complementary approach to investigate human cardiology. Pilia et al. [5] , studied the feasibility of estimating calcium and potassium levels using simulated ECGs with the ten ]o), however, the cell model did not show the results expected based on clinical findings, as APD and QT shortening was observed under hypocalcemic conditions. The reason is that the formulation for the calcium-dependent inactivation of ICaL is not precise enough [6] . Summarizing, a computational model which is able to realistically reproduce the effects of serum calcium changes on the ECG is still lacking. Recently, Himeno et al. [7] presented a human ventricular cell model with refined calcium handling including calciumdependent inactivation of ICaL based on a spatially-resolved Markov formulation. In this work, we used their model to analyze the effects of serum calcium changes on cardiac action potentials (APs) and embedded it in a bi-ventricular ]o, here. Single cell simulations were carried out to extract the AP curve by integrating gating variables with the Rush-Larsen method and the remaining differential equations with the forward Euler method. In order to evaluate the effect of an electrolyte variation on the AP, the following AP parameters were evaluated: amplitude, AP duration at 50% and 90% (APD50 and APD90), resting membrane voltage (RMV) and the maximum of the time derivative of the transmembrane voltage ([dVm/dt]max) describing the steepness of the AP upstroke. The initial state for tissue simulations was pre-calculated in a single cell environment to reach steady state conditions. We proposed reformulations of the Himeno et al. model to adapt it for tissue simulations by including apico-basal and transmural heterogeneities as described in [8] . In this study, we worked with the original Himeno et al. model for simulations on cellular level and with the proposed reformulation of the model on tissue level. The excitation spread in the ventricles was simulated by solving the monodomain equation [9] . For each setup, a 12 lead ECG was computed. Since only ventricular simulations were performed, the P-wave was not part of the simulated ECGs. As described in [5] , transformed signals were calculated to combine information from all leads to one signal. 12 features were extracted from the transformed ECG signals to evaluate the effect of electrolyte changes. The literature generally describes QT segment prolongation during hypocalcemia and QT shortening during hypercalcemia. In this work, we analyzed the RT distance, as a variation of the QT segment directly implies a variation of the RT segment. Moreover, we evaluated the following features: peakedness and amplitude of the T wave, slope of the ascending (asc.) part and of the descending (desc.) part of the T wave, ratio of energy of the first half and of the second half of the T wave to the energy of the whole wave, amplitude of the R peak, energy of the R peak, ratio between the energy and the amplitude of the R peak (R ratio en./amp.), amplitude at 130 ms to evaluate ST elevation and QRS complex duration in lead Einthoven II. For further details regarding feature definition, the reader is referred to [5] .
Results

Action Potential
The results on the AP level are given in Table 1 
ECG
The effects of a [Ca 2+ ]o variation on the analyzed ECG features are shown in Table 2 and Figure 1 
tonous relation (T peakedness), and finally QRS duration which was invariant during hypo-and hypercalcemia.
Discussion
Clinical studies report that the main electrophysiological effect related to hypocalcemia is a prolongation of the APD [4] . Himeno et al. showed that their model is capable to reproduce this effect. However, they only evaluated the results visually [7] . In this work, we studied the changes quantita ]o concentration is taken into account in the Goldman-Hodgkin-Katz equation, we consider that an influence on the RMV plausible, though. APD prolongation was not reported either but we consider it realistic since an increase in the amplitude suggests that the repolarization time is prolonged, too.
[dVm/dt]max is the only value which showed a deviation > 5% with respect to the reference value. The absolute change was very small and almost not visible when analyzing the APs visually. ]o (<1%). We presume that when using measured signals, these deviations will not be identifiable. On tissue level, the dependence of RT distance and ST elevation on [Ca 2+ ]o was clearly visible in the ECGs (see Figure 1) . These two changes due to an alteration in [Ca 2+ ]o were also reported in the literature [4] , [10] . T amplitude, T asc. slope, T desc. slope, R amplitude, R energy and R ratio en./amp. also showed a high dependence on [Ca 2+ ]o changes. However, these features have not been evaluated in literature. We consider these values relevant and suggest to take them into account in future studies. T peakedness showed deviations <4% with respect to the reference value. Thus, we consider it ]o). Our multi-scale simulator based on the Himeno et al. cellular model showed results within the same range as the results from Genovesi-Dossi et al. [13] and a comparable slope to [11] , [12] (Figure 2) . Summarizing, the evaluated results are in line with in vivo findings if these were reported in literature. We also showed the dependence of other features on electrolyte concentrations. Several limitations should be considered regarding this study: we computed ECGs based on the ventricular physiology and torso model of one healthy patient. Future studies could consider CKD-induced electrophysiological remodeling and comprise a bigger number of virtual patients. Moreover, the influence of an electrolyte variation on the P wave was not analyzed as only ventricular simulations were performed.
Conclusion
Our multi-scale simulator realistically models the effects of ]o on the AP and how they translate to changes in the ECG. It additionally proves that the Himeno et al. model is capable of simulating realistic APs and ECGs at different extracellular ionic concentrations. This multi-scale simulator could help to understand the relation between CKD and cardiovascular diseases. The results can also be used for further studies based on the idea of considering the ECG as a non-invasive method to estimate the electrolyte concentrations in the extracellular space [5] , [14] .
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